title: CD30-positive malignant lymphomas: time for a change of management?
authors.forename: Andreas
authors.initials: A
authors.lastname: Engert
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000079963:Brentuximab Vedotin; D002986:Clinical Trials as Topic / Q000639:trends; D019468:Disease Management; D006801:Humans; D018796:Immunoconjugates / Q000494:pharmacology / Q000627:therapeutic use*; D017730:Ki-1 Antigen / Q000096:biosynthesis* / Q000276:immunology*; D008223:Lymphoma / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D018796:Immunoconjugates; D017730:Ki-1 Antigen; D000079963:Brentuximab Vedotin
references.citation: Histopathology. 1990 Apr;16(4):409-13
references.pmid: 2163354
references.citation: Lancet. 2012 May 12;379(9828):1791-9
references.pmid: 22480758
references.citation: Blood. 2003 Aug 15;102(4):1458-65
references.pmid: 12714494
references.citation: J Clin Oncol. 2012 Jun 20;30(18):2190-6
references.pmid: 22614995
references.citation: Haematologica. 2013 Aug;98(8):1232-6
references.pmid: 23645687
references.citation: Int J Cancer. 1982 Oct 15;30(4):445-59
references.pmid: 6754630
references.citation: Haematologica. 2013 Apr;98(4):611-4
references.pmid: 23065511
references.citation: Clin Cancer Res. 2004 Oct 15;10(20):7063-70
references.pmid: 15501986
references.citation: Leuk Lymphoma. 2010 Sep;51(9):1686-91
references.pmid: 20629526
references.citation: Haematologica. 2013 Aug;98(8):1250-8
references.pmid: 23716562
references.citation: J Clin Oncol. 2007 Jul 1;25(19):2764-9
references.pmid: 17515574
references.citation: N Engl J Med. 2010 Nov 4;363(19):1812-21
references.pmid: 21047225
references.citation: Haematologica. 2013 Aug;98(8):e81-2
references.pmid: 23716537
references.citation: Nature. 1982 Sep 2;299(5878):65-7
references.pmid: 7110326
references.citation: Am J Clin Pathol. 1997 Jan;107(1):74-80
references.pmid: 8980371
references.citation: Curr Opin Oncol. 2011 Nov;23(6):587-93
references.pmid: 21986847
references.citation: N Engl J Med. 2012 Nov 8;367(19):1783-91
references.pmid: 23020162
references.citation: Nat Biotechnol. 2003 Jul;21(7):778-84
references.pmid: 12778055
references.citation: J Clin Oncol. 2012 Jun 20;30(18):2183-9
references.pmid: 22454421
references.citation: Blood. 2012 Aug 16;120(7):1470-2
references.pmid: 22786877
references.citation: Blood. 1995 Jan 1;85(1):1-14
references.pmid: 7803786
references.citation: J Clin Oncol. 2005 Jul 20;23(21):4669-78
references.pmid: 16034043
references.citation: Cancer Res. 1990 Jan 1;50(1):84-8
references.pmid: 2152774